Ledger.Open graph →
SEC Form D · filed December 23, 2020

Vivace Therapeutics, Inc

Offering
$30.0M
Sold
$30.0M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
San Mateo, CA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (12)

Leonard Post · San Mateo, CADirectorShuang Qiao · San Bruno, CAExec · DirectorEdward Hu · Orinda, CADirectorTim Shannon · Westport, CTDirectorJun Wu · San Mateo, CADirectorChenguang Zhou · San Mateo, CADirectorLeonard Post · San Bruno, CADirectorShuang Qiao · Orinda, CAExec · DirectorEdward Hu · Orinda, CADirectorTim Shannon · Orinda, CADirectorJun Wu · San Mateo, CADirectorChenguang Zhou · San Mateo, CADirector

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗